About: Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 2007 (uk) article scientifique publié en 2007 (fr) im Jahr 2007 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q57413975-20CB996D-AA5F-455E-9434-C03C28FA0270
publication date	2007-01-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q57413975-132D8185-F905-4B76-9180-F1DDBA94BB57 wds:Q57413975-2FC4E7CD-AAE5-44C5-8AFB-9CFEA04D6201 wds:Q57413975-36055262-1B2A-49D4-A222-BA1FE3435397 wds:Q57413975-40B654FB-408A-438B-A06D-EA2A514BC069 wds:Q57413975-43302DFD-B73B-4852-83D1-208A0ACF2AA3 wds:Q57413975-4E26DAA2-5118-4968-9CEA-1ED348971B6D wds:Q57413975-506280E2-02B0-4E29-8948-9B08339D353A wds:Q57413975-521D735B-2E6A-4393-8359-ACC4A237046A wds:Q57413975-5756CDEC-FACB-4B0A-B75B-9EF92DA0B319 wds:Q57413975-595D082F-CB69-4A60-BDCE-25B4EB43FD06 wds:Q57413975-7193CC61-0972-4AE8-8987-F17B43D7339E wds:Q57413975-767239F9-CB84-4BE5-BD4C-F9A14E9E1CEB wds:Q57413975-84FF6997-6593-4C7C-AC9F-1C00FC2D801A wds:Q57413975-A86001CC-56D2-4B1D-8AC0-085A50D567FD wds:Q57413975-BAEB61AD-6E4C-4700-8603-0FE529AA341D wds:Q57413975-C010DCE3-44F1-47DB-8E5D-DCE75730F112 wds:Q57413975-D072F639-526A-42FA-8FF3-BC807D3EA122 wds:Q57413975-DF667C9F-345A-46CF-A295-2BAE5D0B1E87 wds:Q57413975-FFA281C9-2103-436D-902F-ACAB03ACC2BE
cites work	The Seattle Heart Failure Model: prediction of survival in heart failure Acute heart failure syndromes: current state and framework for future research Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). Risk stratification after hospitalization for decompensated heart failure Diuretic complications Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients Vasopressin V2 Receptor Blockade With Tolvaptan Versus Fluid Restriction in the Treatment of Hyponatremia Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Hyponatremia in congestive heart failure Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST). Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design Relationship between heart failure treatment and development of worsening renal function among hospitalized patients The Neurohumoral Axis in Congestive Heart Failure Relation of loop diuretic dose to mortality in advanced heart failure Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-
author name string	wds:Q57413975-7CD839C8-A7A4-47DC-B56C-A7F21B236A62 wds:Q57413975-938E1AC2-D494-4225-A7BA-3DC5407DC96A wds:Q57413975-B4621EA6-1158-4306-9FE0-11EF0EE954B7
author name string	John Ouyang Melike Bayram David D. Shin
rdfs:label	Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (nl) Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial (en)
skos:prefLabel	Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (nl) Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial (en)
name	Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (nl) Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial (en)
author	wds:Q57413975-2DFD80ED-AE71-4B7A-89FD-ADCECF095193 wds:Q57413975-63859E88-7BA6-49FB-B26B-04D41267538E wds:Q57413975-827F54C4-8BCE-4EE7-ADD4-23BB623A1190 wds:Q57413975-8419D61D-743D-4EA3-9A6D-DC092788E154 wds:Q57413975-B62FE765-B040-47B2-B8DD-1BF6838EDA8C wds:Q57413975-BE3A97C8-BD99-4151-918C-87005DD9AC5A wds:Q57413975-C04C541F-B831-4840-9B85-B8D588ACE603 wds:Q57413975-CD2F224E-FBA7-424E-9A5D-CB20F8129C4E
author	Donald Lloyd-Jones Wendy Gattis Stough James E Udelson Mihai Gheorghiade Kirkwood F Adams Joseph S Rossi Cesare Orlandi Christopher M. Oconnor
title	wds:Q57413975-2A410247-C701-4D4C-858D-559505505978
title	Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial (en)
page(s)	wds:Q57413975-DD2EAD03-A072-4E64-9E48-72BCFFFEBA52
page(s)	82-86
instance of	wds:Q57413975-64A30439-5FB4-4652-81DE-5C014B8A1572
instance of	scholarly article
main subject	wds:Q57413975-0424D2A3-52ED-4AB7-A1A8-2EF5C39B3400 wds:Q57413975-33a2f661-c886-4aee-a196-1beb12822872 wds:Q57413975-E3765848-94E7-4887-A204-97FDC2E23487 wds:Q57413975-E7655A4E-B21A-492C-A121-4968F556954E wds:Q57413975-EED37DF7-F23A-408D-B808-129E5CD9975E
main subject	heart failure hospitalization hyponatremia AVP chronic heart failure
PubMed ID	wds:Q57413975-CC0138AD-F8CB-401E-8F8F-1E59DF7D39EF
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17573581
PubMed ID	17573581
published in	wds:Q57413975-EAFC14FB-F4A2-4600-8B9B-76897668E360
published in	Acute Cardiac Care
issue	wds:Q57413975-BC3274AE-2518-4972-B499-F0B8C60631EB
volume	wds:Q57413975-1F8CADFA-720D-4F07-BDBD-BA5B2D407B2B
issue	2
volume	9
DOI	wds:Q57413975-C8FE1858-955D-430C-847F-D9B6C5E83E09

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 171 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software